Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Glaxo Wellcome files for European approval of lamivudine in HBV

March 26, 1998

IL-10 in clinical testing for multiple indications at Schering-Plough

March 26, 1998

Phase II trial begins with rPAF-AH in pancreatitis

March 17, 1998

Intercardia to license IBD drug

March 13, 1998

Novel gastrointestinal agents in early development at Dainippon

March 12, 1998

New cisapride formulation introduced in U.K.

March 9, 1998

Astra develops new gastric antisecretory agents

March 6, 1998

Triangle Pharmaceuticals obtains license to L-FMAU for HBV treatment

March 5, 1998

NIH will license technology that may lead to new HCV vaccines

March 3, 1998

Profile of a motilide: Abbott's ABT-229

March 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...